Qingdao Vland Biotech INC. (SHA:603739)
China · Delayed Price · Currency is CNY 12.24
+0.39 (3.29%)
Nov 5, 2026, 3:00 PM CST
SHA:603739 Market Cap
SHA:603739 has a market cap or net worth of 3.1 billion as of November 5, 2026. It is the 15,083rd most valuable company in the world and the 4,057th biggest in China. Its market cap has decreased by 21.94% in one year.
Market Cap
3.10B
Enterprise Value
3.38B
Revenue
1.45B
Global Rank
Country Rank
#4,057 China
PE Ratio
42.27
ChartMarket Cap Chart
Since January 16, 2019, SHA:603739's market cap has increased from 2.27B to 3.10B, an increase of 36.50%. That is a compound annual growth rate of 4.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 3.10B | -13.50% |
| Dec 31, 2025 | 3.58B | 18.02% |
| Dec 31, 2024 | 3.03B | -21.22% |
| Dec 29, 2023 | 3.85B | 13.69% |
| Dec 30, 2022 | 3.39B | -27.76% |
| Dec 31, 2021 | 4.69B | 34.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Serum Bio-Technology | 3.32B |
| Hinova Pharmaceuticals | 3.28B |
| Jiangsu Sihuan Bioengineering | 3.26B |
| Xiangxue Pharmaceutical | 3.24B |
| Pulike Biological Engineering | 3.19B |
| Kexing Biopharm | 3.14B |
| Shanghai Shen Lian Biomedical | 2.99B |
| Jiangsu Bioperfectus Technologies | 2.94B |